EP1492873A2 - Genes et proteines lipase - Google Patents

Genes et proteines lipase

Info

Publication number
EP1492873A2
EP1492873A2 EP02787289A EP02787289A EP1492873A2 EP 1492873 A2 EP1492873 A2 EP 1492873A2 EP 02787289 A EP02787289 A EP 02787289A EP 02787289 A EP02787289 A EP 02787289A EP 1492873 A2 EP1492873 A2 EP 1492873A2
Authority
EP
European Patent Office
Prior art keywords
seq
lpdl
lpdlr
sequence
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02787289A
Other languages
German (de)
English (en)
Inventor
Xiao-Yan Wen
A. Keith Stewart
Lap-Chee Tsui
Robert A. Hegele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1492873A2 publication Critical patent/EP1492873A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Les protéines lipase jouent un rôle important dans le métabolisme des lipoprotéines et des lipides des tissus et du plasma et assurent l'hydrolyse de lipides tels que des triglycérides. Diverses maladies sont associées à la fonction lipase : carence en lipase, athérosclérose, stéatose hépatique et dyslipidémies - hypercholestérolemie, hypertriglycéridémie, dyslipidémie mixte (combinée) - états carencés en lipides et lipoprotéines, et/ou tout autre troubles du métabolisme des lipides et lipoprotéines affectant les tissus et plasmas. L'invention concerne deux nouvelles protéines lipase (LPDL et LPDLR) ainsi que les acides nucléiques codant pour lesdites protéines et les séquences régulatrices commandant leur expression génique. L'invention concerne l'utilisation des acides nucléiques LPDL et/ou LPDLR ou de leurs protéines pour la modulation du processus cellulaire dans les états pathologiques ou dans l'homéostase normale de l'énergie. Cette invention concerne également les modulateurs, anticorps, oligonucléotides antisens de ces gènes et protéines ainsi que des analyses diagnostiques, la recherche systématique de mutations, la thérapie génique, l'utilisation de promoteurs pour la commande de l'expression génique, et leur utilisation industrielle dans l'industrie alimentaire et la gestion des déchets. L'invention concerne également des procédés de criblage de médicaments pour LPDL et LPDLR, leur application thérapeutique chez l'homme et leur utilisation sous forme de compositions pharmaceutiques.
EP02787289A 2001-12-21 2002-12-23 Genes et proteines lipase Withdrawn EP1492873A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34178601P 2001-12-21 2001-12-21
US341786P 2001-12-21
US34660302P 2002-01-10 2002-01-10
US346603P 2002-01-10
PCT/CA2002/001998 WO2003055995A2 (fr) 2001-12-21 2002-12-23 Genes et proteines lipase

Publications (1)

Publication Number Publication Date
EP1492873A2 true EP1492873A2 (fr) 2005-01-05

Family

ID=26992663

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02787289A Withdrawn EP1492873A2 (fr) 2001-12-21 2002-12-23 Genes et proteines lipase

Country Status (4)

Country Link
EP (1) EP1492873A2 (fr)
AU (1) AU2002351616A1 (fr)
CA (1) CA2471119A1 (fr)
WO (1) WO2003055995A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015141137A (ja) * 2014-01-29 2015-08-03 国立大学法人大阪大学 小腸由来ｈｄｌの取得方法、小腸由来ｈｄｌの評価方法、小腸由来ｈｄｌ増加作用を有する化合物のスクリーニング方法並びに前記化合物を含む小腸由来ｈｄｌ増加薬及び家族性高コレステロール血症治療薬
CN106884008B (zh) * 2015-12-16 2021-09-24 丰益(上海)生物技术研发中心有限公司 磷脂酶、编码基因及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2327457A1 (fr) * 1998-05-07 1999-11-11 Genetics Institute, Inc. Proteines secretees et polynucleotides codant pour celles-ci
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002024898A2 (fr) * 2000-09-25 2002-03-28 Millennium Pharmaceuticals, Inc. Nouvelle lipase humaine 47647 et utilisations
US20040253221A1 (en) * 2000-10-11 2004-12-16 Hiroyuki Arai Novel pla1
US20040086905A1 (en) * 2001-02-06 2004-05-06 Debopriya Das Lipid-associated molecules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03055995A3 *

Also Published As

Publication number Publication date
AU2002351616A8 (en) 2003-07-15
CA2471119A1 (fr) 2003-07-10
WO2003055995A2 (fr) 2003-07-10
AU2002351616A1 (en) 2003-07-15
WO2003055995A3 (fr) 2003-11-20

Similar Documents

Publication Publication Date Title
JP4726302B2 (ja) Ａｂｃ１ポリペプチドおよびコレステロール水準を調節する方法と試薬
US8343494B2 (en) Antibodies against LLG polypeptides of the triacylglycerol lipase family
JP2003520780A (ja) Ｈｄｌコレステロールとトリグリセリド水準を調節する組成物と方法
Jin et al. Lipase H, a new member of the triglyceride lipase family synthesized by the intestine
Wen et al. Identification of a novel lipase gene mutated in lpd mice with hypertriglyceridemia and associated with dyslipidemia in humans
US7479368B2 (en) Method for detecting subjects having Paget's disease of bone
WO2003055995A2 (fr) Genes et proteines lipase
AU2002319062A1 (en) Paget disease of bone
JP2005528089A (ja) 末梢動脈閉塞疾患の遺伝子
US20100291550A1 (en) Methods and compositions for modulating hair growth
CA2220853A1 (fr) Tyrosine phosphatase pour tissus lymphoides humains
US20050003388A1 (en) Calcium independent phospholipase A2upsilon polynucleotides and polypeptides and methods therefor
Kassim et al. Articles in PresS. Physiol Genomics (May 31, 2011). doi: 10.1152/physiolgenomics. 00006.2011
WO2008042762A2 (fr) Polymorphismes mononucléotidiques associés à la maladie cardiovasculaire
US20020142417A1 (en) Antioxidant protein 2, gene and methods of use therefor
WO2004074302A2 (fr) Acides nucleiques et polypeptides associes a une polykystose renale autosomique recessive
Seidelmann Genetic analysis of murine atherosclerosis
Mailly Mutations in the human lipoprotein lipase gene and their relationship to hyperlipidaemia
Hassan Mutation analysis at the lipoprotein lipase gene locus in two South African kindreds
JP2006504407A (ja) 血管障害、異常脂質血症および関連疾患の治療用の新規治療標的
EP1180243A2 (fr) Utilisation de g nes du type notch

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040720

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

17Q First examination report despatched

Effective date: 20070917

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090310